tradingkey.logo

Vivos Therapeutics Inc

VVOS

3.440USD

+0.100+2.99%
終値 09/19, 16:00ET15分遅れの株価
25.20M時価総額
損失額直近12ヶ月PER

Vivos Therapeutics Inc

3.440

+0.100+2.99%
詳細情報 Vivos Therapeutics Inc 企業名
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
企業情報
企業コードVVOS
会社名Vivos Therapeutics Inc
上場日Dec 11, 2020
最高経営責任者「CEO」Mr. R. Kirk Huntsman
従業員数109
証券種類Ordinary Share
決算期末Dec 11
本社所在地7921 Southpark Plaza,
都市LITTLETON
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号80120
電話番号18669084867
ウェブサイトhttps://vivos.com/
企業コードVVOS
上場日Dec 11, 2020
最高経営責任者「CEO」Mr. R. Kirk Huntsman
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. Sokolow, CPA
Mr. Leonard J. Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. Sokolow, CPA
Mr. Leonard J. Sokolow, CPA
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Appliance sales to integrated providers
1.27M
42.21%
Center revenue
540.00K
17.90%
Sponsorship/seminar
328.00K
10.88%
VIP
223.00K
7.39%
Billing intelligence service
181.00K
6.00%
他の
471.00K
15.62%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Appliance sales to integrated providers
1.27M
42.21%
Center revenue
540.00K
17.90%
Sponsorship/seminar
328.00K
10.88%
VIP
223.00K
7.39%
Billing intelligence service
181.00K
6.00%
他の
471.00K
15.62%
株主
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
株主統計
種類
株主統計
株主統計
比率
Skaff (Michael C.)
11.03%
Luo (Dawei)
7.62%
V-CO Investors, L.L.C.
6.86%
Armistice Capital LLC
3.33%
Intracoastal Capital, L.L.C.
3.05%
他の
68.11%
株主統計
株主統計
比率
Skaff (Michael C.)
11.03%
Luo (Dawei)
7.62%
V-CO Investors, L.L.C.
6.86%
Armistice Capital LLC
3.33%
Intracoastal Capital, L.L.C.
3.05%
他の
68.11%
種類
株主統計
比率
Individual Investor
19.63%
Corporation
9.90%
Investment Advisor
4.63%
Hedge Fund
3.34%
Venture Capital
1.38%
Investment Advisor/Hedge Fund
1.18%
Bank and Trust
0.03%
他の
59.90%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
60
2.22M
33.10%
+944.35K
2025Q1
65
1.44M
22.49%
+733.38K
2024Q4
63
1.28M
22.00%
+869.59K
2024Q3
68
786.28K
18.32%
+305.75K
2024Q2
66
387.48K
12.85%
-179.65K
2024Q1
67
465.07K
19.33%
-62.17K
2023Q4
69
458.43K
25.00%
-105.78K
2023Q3
76
380.33K
31.77%
-57.99K
2023Q2
78
390.56K
32.63%
-94.20K
2023Q1
75
401.83K
33.57%
+53.80K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Skaff (Michael C.)
828.00K
12.33%
+828.00K
--
Jun 09, 2025
V-CO Investors, L.L.C.
514.50K
7.66%
--
--
Jun 09, 2025
Armistice Capital LLC
250.28K
3.73%
+250.28K
--
Sep 30, 2024
Intracoastal Capital, L.L.C.
228.61K
3.4%
+228.61K
--
Dec 30, 2024
UBS Financial Services, Inc.
1.88K
0.03%
+1.49K
+383.03%
Mar 31, 2025
Ionic Ventures LLC
83.00K
1.24%
+83.00K
--
Sep 30, 2024
Huntsman (Ronald Kirk)
73.06K
1.09%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
57.35K
0.85%
+12.52K
+27.93%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
日付
種類
比率
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
Oct 26, 2023
Merger
25→1
KeyAI